Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bray, P. F.
Right arrow Articles by Shuman, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bray, P. F.
Right arrow Articles by Shuman, M. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Identification of an abnormal gene for the GPIIIa subunit of the platelet fibrinogen receptor resulting in Glanzmann's thrombasthenia

PF Bray and MA Shuman

Department of Medicine, University of California, San Francisco 94143- 0128.

The platelet fibrinogen receptor, which is composed of glycoproteins IIb (GPIIb) and IIIa (GPIIIa), belongs to a large family of receptors that participate in a multitude of biologically important adhesive interactions. Platelets from most patients with the autosomal recessive bleeding disorder, Glanzmann's thrombasthenia, are deficient in GPIIb and GPIIIa. We have used cDNA probes to analyze the GPIIb and GPIIIa genes in four patients from three kindreds with Glanzmann's thrombasthenia. Southern analysis of their DNA was identical to that observed in normals when probed with a full-length GPIIb cDNA or a 3' GPIIIa cDNA. However, in one family, a 5' 2.0 kb GPIIIa cDNA identified abnormal DNA fragments in the father and two affected siblings' genes. A series of restriction digests resulting in small genomic fragments were probed with portions of the 5' 2.0 kb GPIIIa cDNA and indicated that the abnormal sequences are flanked by normal fragments of the GPIIIa gene. To analyze further the genetic defect in this family, RNA was prepared from their platelets. Northern analysis revealed normal levels of GPIIb mRNA compared to control platelets. We were unable to identify GPIIIa mRNA of any size in the clinically affected family members. We also identified an EcoRI restriction fragment length polymorphism (RFLP) that permitted carrier status determination in the clinically unaffected siblings. These studies indicate that Glanzmann's thrombasthenia can be caused by heterogeneous defects in the GPIIIa gene. Furthermore, we have shown that platelets can be used to characterize normal and abnormal GPIIIa and GPIIb mRNA, and RFLPs may be used to determine the carrier status in some families with Glanzmann's thrombasthenia. The specific gene abnormality in this family appears to represent an example of an insertional mutation resulting in a human disease.

Volume 75, Issue 4, pp. 881-888, 02/15/1990
Copyright © 1990 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Vet PatholHome page
P. W. Christopherson, T. A. Insalaco, V. L. van Santen, L. Livesey, C. Bourne, and M. K. Boudreaux
Characterization of the cDNA Encoding {alpha}IIb and {beta}3 in Normal Horses and Two Horses with Glanzmann Thrombasthenia
Vet. Pathol., January 1, 2006; 43(1): 78 - 82.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
M. K. Boudreaux and D. L. Lipscomb
Clinical, Biochemical, and Molecular Aspects of Glanzmann's Thrombasthenia in Humans and Dogs
Vet. Pathol., May 1, 2001; 38(3): 249 - 260.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
D. L. Lipscomb, C. Bourne, and M. K. Boudreaux
Two Genetic Defects in {alpha}IIb Are Associated with Type I Glanzmann's Thrombasthenia in a Great Pyrenees Dog: A 14-base Insertion in Exon 13 and a Splicing Defect of Intron 13
Vet. Pathol., November 1, 2000; 37(6): 581 - 588.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Jin, C. C. Wilhide, C. Dang, L. Li, S.-X. Li, M. Villa-Garcia, and P. F. Bray
Human Integrin beta 3 Gene Expression: Evidence for a Megakaryocytic Cell-Specific cis-Acting Element
Blood, October 15, 1998; 92(8): 2777 - 2790.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M.-C. Morel-Kopp, C. Kaplan, V. Proulle, V. Jallu, C. Melchior, O. Peyruchaud, M.-H. Aurousseau, and N. Kieffer
A Three Amino Acid Deletion in Glycoprotein IIIa Is Responsible for Type I Glanzmann's Thrombasthenia: Importance of Residues Ile325Pro326Gly327 for beta 3 Integrin Subunit Association
Blood, July 15, 1997; 90(2): 669 - 677.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. J. Samani and D. Lodwick
Glycoprotein IIIa polymorphism and risk of myocardial infarction
Cardiovasc Res, March 1, 1997; 33(3): 693 - 697.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
M. Bertagnolli, S. Locke, M. Hensler, P. Bray, and M. Beckerle
Talin distribution and phosphorylation in thrombin-activated platelets
J. Cell Sci., January 12, 1993; 106(4): 1189 - 1199.
[Abstract] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1990 by American Society of Hematology         Online ISSN: 1528-0020